Efficacy and safety of simultaneous treatment with two biologic medications in refractory Crohn’s disease-Reference-Cited by-同舟云学术

Efficacy and safety of simultaneous treatment with two biologic medications in refractory Crohn’s disease

Published:2020-04-24 Issue:11 Volume:51 Page:1031-1038
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Yang Edward¹^ORCID,Panaccione Nicola²,Whitmire Natalie¹,Dulai Parambir S.¹^ORCID,Vande Casteele Niels¹^ORCID,Singh Siddharth¹^ORCID,Boland Brigid S.¹,Collins Angelina¹,Sandborn William J.¹^ORCID,Panaccione Remo³,Battat Robert¹⁴^ORCID

Affiliation:

1. UCSD Inflammatory Bowel Disease Center; Division of Gastroenterology; Department of Medicine; La Jolla CA USA

2. Faculty of Health Science; Western University; London ON Canada

3. University of Calgary Inflammatory Bowel Disease Center; Division of Gastroenterology; Department of Medicine; Calgary AB Canada

4. Jill Roberts Center for IBD; Division of Gastroenterology and Hepatology; Weill Cornell Medicine; New York NY USA

Funder

National Institute of Diabetes and Digestive and Kidney Diseases

American Gastroenterology Association Research Scholar Award

AbbVie

Allergan

Amgen

Boehringer Ingelheim

Celgene

Ferring

Genentech

Gilead Sciences

Kyowa Kirin

Lilly

Pfizer

Shire

UCB

Pharmaceuticals

Prometheus

AstraZeneca

Baxter

Biogen

Bristol-Myers Squibb

Elan

Genzyme

Gilead

Human Genome Sciences

Novo Nordisk

Merck

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/apt.15719/fullpdf

Reference27 articles.

1. ACG clinical guideline: management of Crohn's disease in adults;Lichtenstein;Am J Gastroenterol,2018

2. Risk factors associated with progression to intestinal complications of Crohn's disease in a population-based cohort;Thia;Gastroenterology,2010

3. Risk factors for surgery and postoperative recurrence in Crohn's disease;Bernell;Ann Surg,2000

4. Cumulative incidence of second intestinal resection in Crohn's disease: a systematic review and meta-analysis of population-based studies;Frolkis;Am J Gastroenterol,2014

5. Novel therapies and treatment strategies for patients with inflammatory bowel disease;Duijvestein;Curr Treat Options Gastroenterol,2018

Cited by 89 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combined Advanced Targeted Therapy in Inflammatory Bowel Diseases: An Extensive Update;Inflammatory Bowel Diseases;2024-08-29

2. Rare extraintestinal manifestations of ulcerative colitis treated with dual biologic therapy: A case report;World Journal of Clinical Cases;2024-08-16

3. The potential for medical therapies to address fistulizing Crohn’s disease: a state-of-the-art review;Expert Opinion on Biological Therapy;2024-07-24

4. Positioning Crohn’s Disease Therapies in the Era of Small Molecules and Combination Therapies;Current Gastroenterology Reports;2024-07-06

5. IBD Matchmaking - Rational Combination Therapy;Clinical Gastroenterology and Hepatology;2024-07